Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose vs Monthly Cyclophosphamide in Severe Lupus
NCT00005778Phase 3Completed
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Start
- Jan 2000
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide in systemic lupus erythematosus (SLE), sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Started Jan 2000; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00005778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005778.